Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial
ESGO eAcademy. Leon-Castillo A. 11/02/19; 286496 Topic: Epidemiology/prognostic/predictive factors
Alicia Leon-Castillo
Alicia Leon-Castillo

Access to Premium content is currently a membership benefit.


Click here to join ESGO or renew your membership.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies